[ET Net News Agency, 10 January 2022] ALI HEALTH (00241) rose 10.35% to HK$6.93,
breaking above the 20-D SMA of HK$6.662.
It hits an intra-day high of HK$6.94, and an intra-day low of HK$6.21. The total shares
traded was 29.57 million, with a value of HK$195.63m. The active buy/sell ratio is 63:37,
with net buying turnover of HK$51.2m. CITIGROUP GLOBAL accounts for greatest net
responsive buying turnover of HK$21.25m, with volume weighted average price of HK$6.653.
MORGAN STANLEY HK SEC accounts for greatest net responsive selling turnover of HK$11.01m,
with volume weighted average price of HK$6.557. The stock has risen a combined 20.1% over
the past 3 consecutive trading days.
The Hang Seng Index now rose 199 points, or 0.85% to 23,693; the Hang Seng China
Enterprises Index now rose 92 points, or 1.12% to 8,323; the Hang Seng TECH Index now rose
109 points, or 1.98% to 5,613; with an overall turnover of HK$49b.
The SSE Composite Index now rose 2 points, or 0.07% to 3,582, with an overall turnover
of RMB213.68b.
The SZSE Component Index now rose 47 points, or 0.33% to 14,391, with an overall
turnover of RMB142.07b.
Basic Information
=================
----------------------------------
Nominal 6.930 % Chg +10.35%
High 6.940 Low 6.210
Shares Tr 29.57m Turnover 195.63m
10-D SMA 6.297 %H.V 59.499
20-D SMA 6.662 VWAP 6.616
50-D SMA 7.742 RSI14 50.170
----------------------------------
Status: Breaking above the 20-D SMA, active buy/sell ratio is 63:37, with net buying
turnover of HK$51.2m, rising a combined 20.1% over the past 3 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
ALI HEALTH (00241) 6.930 +10.35
PASHUN INT'L (00574) 0.068 +11.48
SINOPHARM (01099) 18.000 +1.69
PIONEER PHARM (01345) 1.640 +0.61
UNI HEALTH (02211) 0.148 -1.33
TONGRENTANGCM (03613) 12.460 +1.96
JD HEALTH (06618) 62.200 +8.84
SINCO PHARMA (06833) 2.140 +7.00
---------------------------------------------
(ed)